These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30867615)

  • 1. NIH supports call for moratorium on clinical uses of germline gene editing.
    Wolinetz CD; Collins FS
    Nature; 2019 Mar; 567(7747):175. PubMed ID: 30867615
    [No Abstract]   [Full Text] [Related]  

  • 2. Germline-editing moratorium - why we should resist it.
    König H
    Nature; 2019 Apr; 568(7753):458. PubMed ID: 31015691
    [No Abstract]   [Full Text] [Related]  

  • 3. Trust in Science: CRISPR-Cas9 and the Ban on Human Germline Editing.
    Guttinger S
    Sci Eng Ethics; 2018 Aug; 24(4):1077-1096. PubMed ID: 28653169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline Genome Editing and the Functions of Consent.
    Ranisch R
    Am J Bioeth; 2017 Dec; 17(12):27-29. PubMed ID: 29148947
    [No Abstract]   [Full Text] [Related]  

  • 5. [Application of clustered regularly interspaced short palindromic repeats- associated protein 9 gene editing technology for treatment of HBV infection].
    Wang YD; Liang QF; Li ZY; Zhao CY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Nov; 26(11):860-864. PubMed ID: 30616324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GENETIC ENGINEERING. Germline editing dominates DNA summit.
    Travis J
    Science; 2015 Dec; 350(6266):1299-300. PubMed ID: 26659031
    [No Abstract]   [Full Text] [Related]  

  • 7. Questioning the proposed translational pathway for germline genome editing.
    Baylis F
    Nat Hum Behav; 2019 Mar; 3(3):200. PubMed ID: 30953019
    [No Abstract]   [Full Text] [Related]  

  • 8. Genome Editing: The Recent History and Perspective in Cardiovascular Diseases.
    Musunuru K
    J Am Coll Cardiol; 2017 Dec; 70(22):2808-2821. PubMed ID: 29191331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 30 Years of Safe Genetic Engineering in Germany.
    Lütz S; Liese A
    Angew Chem Int Ed Engl; 2020 Aug; 59(33):13668-13669. PubMed ID: 32488941
    [No Abstract]   [Full Text] [Related]  

  • 10. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Council of Europe and the prohibition on human germline genome editing.
    Baylis F; Ikemoto L
    EMBO Rep; 2017 Dec; 18(12):2084-2085. PubMed ID: 29141984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Germline CRISPR-Cas Modification: Toward a Regulatory Framework.
    Evitt NH; Mascharak S; Altman RB
    Am J Bioeth; 2015; 15(12):25-9. PubMed ID: 26632357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human germline editing: a historical perspective.
    Morange M
    Hist Philos Life Sci; 2017 Oct; 39(4):34. PubMed ID: 29038945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. He Jiankui´s gene-editing experiment and the non-identity problem.
    Alonso M; Savulescu J
    Bioethics; 2021 Jul; 35(6):563-573. PubMed ID: 33951203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Editing Using CRISPR: Why the Excitement?
    Komaroff AL
    JAMA; 2017 Aug; 318(8):699-700. PubMed ID: 28796848
    [No Abstract]   [Full Text] [Related]  

  • 17. [Genome editing ~Principle and possibility of a novel genetic engineering technology. Basic principles of genome editing.].
    Yamamoto T
    Clin Calcium; 2017; 27(11):1638-1644. PubMed ID: 29074838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shaping the CRISPR Gene-Editing Debate: Questions About Enhancement and Germline Modification.
    Johnston J
    Perspect Biol Med; 2020; 63(1):141-154. PubMed ID: 32063593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Governing Human Germline Editing Through Patent Law.
    Sherkow JS; Adashi EY; Cohen IG
    JAMA; 2021 Sep; 326(12):1149-1150. PubMed ID: 34459849
    [No Abstract]   [Full Text] [Related]  

  • 20. Biotechnology. A prudent path forward for genomic engineering and germline gene modification.
    Baltimore D; Berg P; Botchan M; Carroll D; Charo RA; Church G; Corn JE; Daley GQ; Doudna JA; Fenner M; Greely HT; Jinek M; Martin GS; Penhoet E; Puck J; Sternberg SH; Weissman JS; Yamamoto KR
    Science; 2015 Apr; 348(6230):36-8. PubMed ID: 25791083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.